STK38L and diabetic retinopathy: Our results extend this paradigm by positioning NDR2 as a novel upstream regulator of microglial metabolic adaptability under hyperglycemia, linking impaired metabolic flexibility to mitochondrial dysfunction, dysregulated cytokine production, and ultimately neurovascular pathology in diabetic retinopathy.